Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
In: Emerging Infectious Diseases, Jg. 6 (2000-11-01), Heft 6, S. 585-594
Online
academicJournal
Zugriff:
We examined the long-term efficacy of praziquantel against Schistosoma haematobium, the causative agent of urinary schistosomiasis, during a school-based treatment program in the Msambweni area of Coast Province, Kenya, where the disease is highly endemic. Our results, derived from treating 4,031 of 7,641 children from 1984 to 1993, indicate substantial year-to- year variation in drug efficacy. However, the pattern of this variation was not consistent with primary or progressive emergence of praziquantel resistance. Mathematical modeling indicated that, at current treatment rates, praziquantel resistance will likely take 10 or more years to emerge. [ABSTRACT FROM AUTHOR]
Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
|
---|---|
Autor/in / Beteiligte Person: | King, Charles H. ; Muchiri, Eric M. ; Ouma, John H. ; King, C H ; Muchiri, E M ; Ouma, J H |
Link: | |
Zeitschrift: | Emerging Infectious Diseases, Jg. 6 (2000-11-01), Heft 6, S. 585-594 |
Veröffentlichung: | 2000 |
Medientyp: | academicJournal |
ISSN: | 1080-6040 (print) |
DOI: | 10.3201/eid0606.000606 |
Schlagwort: |
|
Sonstiges: |
|